The gut microenvironment in antibody-mediated rejection: from conventional immunosuppression to precision immunomodulation in organ transplantation
- 1Bio Ameka
Abstract
The gut microbiota and broader gut microenvironment, comprising microbiota-derived metabolites and host–microbial interactions, have emerged as potentially modifiable factors associated with host immune regulation and have been implicated in altered drug responsiveness, immune-mediated diseases, and metabolic disorders. Accumulating evidence suggests that the gut microenvironment may modulate post-transplant immune responses and may provide candidate biomarkers and therapeutic targets in organ transplantation. Gut dysbiosis has been associated with immune dysregulation and adverse allograft outcomes, although direct causal evidence in human AMR remains limited. Profiling the gut microenvironment may therefore complement conventional immune monitoring for post-transplant risk stratification. In this review, current evidence on the interactions among the gut microbiota, microbiota-derived metabolites, and host immune regulation is synthesized, with particular emphasis on the role of the gut microenvironment in maintaining immune homeostasis and influencing transplant outcomes. The impact of alterations in the gut microenvironment on the development of antibody-mediated rejection—a major barrier to long-term graft survival—is examined by focusing on their effects on regulatory immune pathways and inflammatory responses. The potential role of microbiota-derived metabolites in promoting immune tolerance and graft accommodation, two complementary mechanisms that contribute to long-term allograft protection, is also discussed. Finally, gut microenvironment-based strategies for early diagnosis, risk stratification, and rejection prediction are evaluated, alongside therapeutic interventions including prebiotics, probiotics, synbiotics, postbiotics, and fecal microbiota transplantation. These strategies may facilitate pre-emptive intervention before irreversible graft injury develops and support a shift from conventional immunosuppression towards precision immunomodulation in transplantation medicine.
Related
- Immunomodulation and biofilm disruption of piezoelectric materials in bone infection
- Macrophage-derived exosomes in bone tissue regeneration: spatiotemporal immunomodulation, engineering advances, and translational frontiers.
- Immune cell β2-adrenergic receptor signaling in myocardial injury: from neuroimmune crosstalk to precision immunomodulation
- Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles for Immunomodulation in Osteoarthritis
- Mesenchymal stem cell-derived extracellular vesicles in diabetes: immunomodulation and therapeutic prospects
BibTeX
@article{matsuda2026microenvironment,
title = {{The gut microenvironment in antibody-mediated rejection: from conventional immunosuppression to precision immunomodulation in organ transplantation}},
author = {Yoshiko Matsuda},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1968780},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968780/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The gut microenvironment in antibody-mediated rejection: from conventional immunosuppression to precision immunomodulation in organ transplantation
AU - Yoshiko Matsuda
PY - 2026
DA - 2026/10/08
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1968780
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1968780/full
AB - The gut microbiota and broader gut microenvironment, comprising microbiota-derived metabolites and host–microbial interactions, have emerged as potentially modifiable factors associated with host immune regulation and have been implicated in altered drug responsiveness, immune-mediated diseases, and metabolic disorders. Accumulating evidence suggests that the gut microenvironment may modulate post-transplant immune responses and may provide candidate biomarkers and therapeutic targets in organ transplantation. Gut dysbiosis has been associated with immune dysregulation and adverse allograft outcomes, although direct causal evidence in human AMR remains limited. Profiling the gut microenvironment may therefore complement conventional immune monitoring for post-transplant risk stratification. In this review, current evidence on the interactions among the gut microbiota, microbiota-derived metabolites, and host immune regulation is synthesized, with particular emphasis on the role of the gut microenvironment in maintaining immune homeostasis and influencing transplant outcomes. The impact of alterations in the gut microenvironment on the development of antibody-mediated rejection—a major barrier to long-term graft survival—is examined by focusing on their effects on regulatory immune pathways and inflammatory responses. The potential role of microbiota-derived metabolites in promoting immune tolerance and graft accommodation, two complementary mechanisms that contribute to long-term allograft protection, is also discussed. Finally, gut microenvironment-based strategies for early diagnosis, risk stratification, and rejection prediction are evaluated, alongside therapeutic interventions including prebiotics, probiotics, synbiotics, postbiotics, and fecal microbiota transplantation. These strategies may facilitate pre-emptive intervention before irreversible graft injury develops and support a shift from conventional immunosuppression towards precision immunomodulation in transplantation medicine.
SN - 1664-3224
ER -